Presidio HCC

Liver malignancy, one of the major causes for liver transplantation, can affect the medical urgency of a patient on the wait list by allowing an increase of the MELD score. The Presidio HCC (Hepatocellular Carcinoma) application has been developed to help manage patients with HCC and to address UNOS wait list urgency criteria.

Download brochure pdf_icon

Events and Activities Supported

  • Preliminary evaluation—medical history and preliminary exam
  • Radiology testing—PET scan, CT scan, Ultrasound and/or MRI
  • Pathology testing
  • Tumor stages
  • Treatment plan
  • Treatment and follow-up
  • Evaluation

Radiology Testing

Reporting functionality that includes: location (segment), signal intensity, dynamic series, lesion definition, vascular thrombus and other measurement scores such as LRI, Milan and UCSF criteria.

Pathology Testing

Reporting functionality includes all of the data required by UNOS and the number of tumors and locations. The pathological data maps to the required UNOS “Liver Recipient Explant Pathology” report.

Tumor Stages

Tumor stages can be defined based on the TNM data entered by analyzing the diagnostic test data.

Treatment Plan, Treatment, and Follow-Up

Tumors discovered by radiology and/or pathology testing can have specific treatments that may be tailored to an individual tumor.

The treatment plan is defined and recorded initially and can change over time. The plan can include one or more of the
following courses of treatment:

  • Interventional radiology
  • Chemotherapy
  • Surgical

The specific details of each applied treatment can be recorded as well.

%d bloggers like this: